Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3307857 | 0.97 | ALDH1A1 (0.32) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL3431851 | 0.95 | MEN1 (0.36) | ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL2242804 | 0.92 | SMN1; SMN2 (0.36) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL20203579 | 0.90 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2MEN1KMT2ALMNA | |
| Water SCHEMBL3302512 | 0.89 | SMN1; SMN2 (0.35) | ALDH1A1SMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL23792422 | 0.88 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL26267228 | 0.88 | MEN1 (0.37) | MEN1KMT2A | |
| SCHEMBL1403832 | 0.87 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL23736384 | 0.87 | MEN1 (0.35) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL23736390 | 0.85 | ALDH1A1 (0.36) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116948250-A | Method for forming coated calcium oxide by degrading polyurethane foam and application of coated calcium oxide | 郑州航空工业管理学院 | 2023-10-27 | — | — | CN | claimed |
| US-11090603-B2 | Acidic gas absorbent, acidic gas removal method and acidic gas removal apparatus | KABUSHIKI KAISHA TOSHIBA (JP) | 2021-08-17 | — | — | US | claimed |
| WO-2024095923-A1 | CLEANING LIQUID AND METHOD FOR CLEANING SUBSTRATE | 東京応化工業株式会社 | 2024-05-10 | — | — | WO | disclosed |
| CN-116948250-A | Method for forming coated calcium oxide by degrading polyurethane foam and application of coated calcium oxide | 郑州航空工业管理学院 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023067125-A1 | OLIGOSACCHARIDE COMPLEXES AND USES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023067123-A1 | OLIGOSACCHARIDE COMPLEXES AND USES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| US-20230104687-A1 | NOVEL AMINE COMPOUND, ACID GAS ABSORBENT, METHOD FOR REMOVING ACID GAS, AND ACID GAS REMOVAL APPARATUS | KABUSHIKI KAISHA TOSHIBA (JP) | 2023-04-06 | — | — | US | disclosed |
| US-20220153746-A1 | NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2022-05-19 | — | — | US | disclosed |
| WO-2022096930-A2 | NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2022-05-12 | — | — | WO | disclosed |
| US-11090603-B2 | Acidic gas absorbent, acidic gas removal method and acidic gas removal apparatus | KABUSHIKI KAISHA TOSHIBA (JP) | 2021-08-17 | — | — | US | disclosed |
| US-7994250-B2 | Vinyl-urethane copolymers with intermediary linkage segments having silicon-oxygen bonds and production methods thereof | KONISHI CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| EP-1837360-A1 | VINYL-URETHANE COPOLYMER AND METHOD FOR PRODUCING SAME | Konishi Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070117902-A1 | Vinyl-urethane copolymers and production methods thereof | KONISHI CO., LTD. (JP) | 2007-05-24 | — | — | US | disclosed |
| US-4980140-A | Selective removal of carbonyl sulfide from a hydrogen sulfide containing gas mixture | SHELL OIL COMPANY (US) | 1990-12-25 | — | — | US | disclosed |
| US-4770862-A | SORBENT SOLUTION OF A TERTIARY AMINE AND A LOWER ALKANE DIOL OR POLYOL | SHELL OIL COMPANY (US) | 1988-09-13 | — | — | US | disclosed |
| EP-0054151-B1 | PHOTOPOLYMERISABLE RECORDING MATERIAL AND PROCESS FOR THE PRODUCTION OF RELIEF FORMS BY MEANS OF THIS RECORDING MATERIAL | BASF Aktiengesellschaft (DE) | 1984-01-04 | — | — | EP | disclosed |
| US-4421840-A | Photopolymerizable recording material containing a diisocyanate modified nylon binder | BASF AKTIENGESELLSCHAFT (DE) | 1983-12-20 | — | — | US | disclosed |
| EP-0054151-A1 | Photopolymerisable recording material and process for the production of relief forms by means of this recording material | BASF Aktiengesellschaft (DE) | 1982-06-23 | — | — | EP | disclosed |
| EP-0054150-A1 | Photopolymerisable recording material and process for the production of relief forms by means of this recording material | BASF Aktiengesellschaft (DE) | 1982-06-23 | — | — | EP | disclosed |
| US-4190601-A | Production of tertiary amines by reductive alkylation | UNION CARBIDE CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153746-A1 | NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF | PDE6G, PRKG1, PDE6D | ALDH1A1 4173/4885MAPT 3374/4885SMN1; SMN2 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.